Search
Actuate Therapeutics Inc
ACTUAdd to Watchlist
0.732USD
-0.075-9.29%
Close 09-23 16:00（ET）
17.52MMarket Cap
LossP/E TTM
After-hours 18:34 (ET)0.710USD-0.023-3.14%
After-hours 18:34 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-9.29%
5 Days
-26.58%
1 Month
-42.36%
6 Months
-70.00%
Year to Date
-88.04%
1 Year
-89.36%
Key Figures
0.800Open
0.930High
11.40KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
0.807Prev. Close
0.725Low
8.89KTurnover
LossP/E Static
17.73P/B
0.00%Div Yield TTM
-321.58%ROA
8.49052wk High
0.06Volume Ratio
-27.29MNet Profit
23.93MShares
-0.9724EPS TTM
--Beta
-553.75%ROE
0.72552wk Low
25.40%Amplitude
--Gross Margin
17.52MMarket Cap
-4.81Reward/Risk
6.50%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Actuate Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.20/-0.19
Revenue / Forecast
--/0.00
Actuate Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolACTU
Number of employees10
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Bios Equity Partners, LP. | 42.40% |
| Kairos Ventures LLC | 9.81% |
| Voss Capital LLC | 7.65% |
| Schmitt (Daniel M.) | 3.70% |
| Shareholder Types | Proportion |
|---|---|
| Venture Capital | 42.40% |
| Corporation | 9.81% |
| Hedge Fund | 7.66% |
| Investment Advisor | 5.34% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%
FAQs
What is the current price of Actuate Therapeutics Inc (ACTU)?
The current price of Actuate Therapeutics Inc (ACTU) is 0.73.
What is the symbol of Actuate Therapeutics Inc?
The ticker symbol of Actuate Therapeutics Inc is ACTU.
What is the 52-week high of Actuate Therapeutics Inc?
The 52-week high of Actuate Therapeutics Inc is 8.49.
What is the 52-week low of Actuate Therapeutics Inc?
The 52-week low of Actuate Therapeutics Inc is 0.72.
What is the market capitalization of Actuate Therapeutics Inc?
The market capitalization of Actuate Therapeutics Inc is 17.52M.
Is Actuate Therapeutics Inc (ACTU) currently rated as Buy, Hold, or Sell?
According to analysts, Actuate Therapeutics Inc (ACTU) has an overall rating of Buy, with a price target of 11.67.
What is the Earnings Per Share (EPS TTM) of Actuate Therapeutics Inc (ACTU)?
The Earnings Per Share (EPS TTM) of Actuate Therapeutics Inc (ACTU) is -0.97.